Adropin deficiency and/or Enho mutations play a key role in lung damage caused by myeloperoxidase anti-neutrophil cytoplasmic antibodies (MPO-ANCA). This evidence concerns the gene MPO and hyperinsulinemic hypoglycemia, familial, 4.